GetTopicDetailResponse(id=4416149981e, topicName=Qtrilmet, introduction=Qtrilmet, content=null, image=null, comments=1, allHits=618, url=https://h5.medsci.cn/topic?id=14998, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=96836, tagList=[TagDto(tagId=96836, tagName=Qtrilmet)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1792933, encodeId=4dc51e92933e7, content=<a href='/topic/show?id=4416149981e' target=_blank style='color:#2F92EE;'>#Qtrilmet#</a>, objectTitle=阿斯利康的三合一藥物Qtrilmet獲得歐盟批準，用于II型糖尿病, objectType=article, longId=183117, objectId=d3c118311e3e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d3c118311e3e, replyNumber=0, likeNumber=96, createdTime=2020-08-31, rootId=0, userName=xiaoyang_ambs, userId=4736501, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d3c118311e3e, moduleTitle=阿斯利康的三合一藥物Qtrilmet獲得歐盟批準，用于II型糖尿病, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=d3c118311e3e)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
